Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genicular artery embolization vs corticosteroid injection for knee osteoarthritis
NCT05818150Active, not recruiting
- Sponsor
- Merit Medical Systems
- Start
- Jan 2024
- Primary completion
- Apr 2026
- Countries
- 6
01
Overview
Randomised, open-label trial (2 arms), sponsored by Merit Medical Systems. Primary endpoints: Primary Efficacy Endpoint at 6 months and Primary Safety Endpoint at 6 months. Started Jan 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT05818150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05818150.